drugset / Trial / NCT00154115
Levosimendan in High Risk Heart Valve Surgery
RandomizedParallel-groupTriple-blindTreatment
Summary
Prospective, randomized, double blind study investigating the efficacy of levosimendan in heart failure after cardiac surgery. Study hypothesis: Levosimendan diminishes the need for adrenergic inotropic drugs and morbidity and may improve survival after heart valve surgery.
Timeline
- Start
- 2005-03
- Primary completion
- 2008-12
- Completion
- 2008-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Levosimendan | Other / unclassified | 0.2 ug/kg | Intravenous |